首页> 外文期刊>Diagnostic microbiology and infectious disease >Phenotypic and genotypic characterizations of Chinese strains of Escherichia coli producing extended-spectrum beta-lactamases.
【24h】

Phenotypic and genotypic characterizations of Chinese strains of Escherichia coli producing extended-spectrum beta-lactamases.

机译:中国大肠埃希菌产生广谱β-内酰胺酶的表型和基因型特征。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Twenty-three multi-resistant strains of Escherichia coli were isolated at a single hospital in Beijing, China between January 1997 and May 1998. All isolates produced extended spectrum beta-lactamases (ESBLs) as detected by the double disk synergy test and the Etest ESBL strip (AB BIODISK, Solna Sweden). Additional antimicrobial susceptibility testing showed that most isolates were resistant to gentamicin, tobramycin, tetracycline, trimethoprim/sulfamethoxazole, ciprofloxacin, and cefepime. All isolates remained susceptible to imipenem with MICs of < or = 0.5 microgram/ml. The isolates each produced several beta-lactamases (range 1-4 enzymes/strain) with pI values ranging from 5.2-8.4. Molecular epidemiologic typing revealed four ribotypes and eight pulsed field gel electrophoresis (PFGE) patterns with subgroups among the 23 isolates. Clusters of isolates with the same DNA type were observed as follows (ribotype/PFGE): Wards A (242-5/2, and 242-5/3a), B (242-5/4), and C (880-1/1a). Moreover, similar molecular types were observed in patients from two or more different wards. Further use of isoelectric focusing results and co-resistance patterns produced evidence of potential nosocomial dissemination of strains in only two instances (two identical strains on one ward and two identical strains on different wards). There were also strong similarities in beta-lactamase pIs and co-resistances among many of the strains throughout this medical center. These data document the wide genetic diversity among E. coli producing ESBLs, and a potential for nosocomial spread of these highly resistant organisms requiring increasingly more sophisticated molecular-based techniques and local interventions.
机译:在1997年1月至1998年5月间,在中国北京的一家医院中分离出了23株具有多重耐药性的大肠杆菌。通过双盘协同试验和Etest ESBL检测,所有分离株均产生了广谱的β-内酰胺酶(ESBLs)。带材(AB BIODISK,瑞典索尔纳)。附加的药敏试验表明,大多数分离株对庆大霉素,妥布霉素,四环素,甲氧苄氨嘧啶/磺胺甲恶唑,环丙沙星和头孢吡肟有抗药性。所有分离株仍对亚胺培南敏感,MIC≤0.5微克/毫升。每个分离物产生几种β-内酰胺酶(1-4个酶/菌株),pI值在5.2-8.4之间。分子流行病学分型显示23种分离株中有4个核糖型和8个脉冲场凝胶电泳(PFGE)模式以及亚组。观察到以下具有相同DNA类型的分离株的簇(核型/ PFGE):病房A(242-5 / 2和242-5 / 3a),病房A(242-5 / 4)和病房C(880-1) / 1a)。此外,在两个或多个不同病房的患者中观察到了相似的分子类型。等电聚焦结果和共电阻模式的进一步使用提供了仅两种情况下菌株在医院内潜在传播的证据(一个病房有两个相同的菌株,而不同病房有两个相同的菌株)。在整个医学中心的许多菌株中,β-内酰胺酶的pI和共耐药性也有很强的相似性。这些数据记录了产生大肠杆菌的ESBLs之间的广泛遗传多样性,以及这些高耐药性生物在医院内传播的潜力,需要越来越先进的基于分子的技术和本地干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号